- Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?
-
Ryan DH
- KMID: 2521069
- J Obes Metab Syndr.
- 2021 Sep;30(3):196-208.
- doi: 10.7570/jomes21033
There is a new generation of antiobesity drugs in development or just arriving on the scene. First, setmelanotide has been approved for three of the ultrarare genetic conditions that cause... -
- CITED
-
- Close
- SHARE
-
- Close
